Consensus statement on the investigation and management of non-radiographic axial spondyloarthritis (nr-axSpA)
- PMID: 24673897
- DOI: 10.1111/1756-185X.12358
Consensus statement on the investigation and management of non-radiographic axial spondyloarthritis (nr-axSpA)
Abstract
Aim: Non-radiographic axial spondyloarthritis (nr-axSpA) is axial inflammatory arthritis where plain radiographic damage is not evident. An unknown proportion of these patients will progress to ankylosing spondylitis (AS). The increasing recognition of nr-axSpA has been greatly assisted by the widespread use of magnetic resonance imaging. The aim of this article was to construct a set of consensus statements based on a literature review to guide investigation and promote best management of nr-axSpA.
Methods: A literature review using Medline was conducted covering the major investigation modalities and treatment options available. A group of rheumatologists and a radiologist with expertise in investigation and management of SpA reviewed the literature and formulated a set of consensus statements. The Grade system encompassing the level of evidence and strength of recommendation was used. The opinion of a patient with nr-axSpA and a nurse experienced in the care of SpA patients was also sought and included.
Results: The literature review found few studies specifically addressing nr-axSpA, or if these patients were included, their results were often not separately reported. Fourteen consensus statements covering investigation and management of nr-axSpA were formulated. The level of agreement was high and ranged from 8.1 to 9.8. Treatment recommendations vary little with established AS, but this is primarily due to the lack of available evidence on the specific treatment of nr-axSpA.
Conclusion: The consensus statements aim to improve the diagnosis and management of nr-axSpA. We aim to raise awareness of this condition by the public and doctors and promote appropriate investigation and management.
Keywords: ankylosing spondylitis; non-radiographic axial spondyloarthritis; spondyloarthritis; tumor necrosis factor-alpha inhibitors.
© 2014 Asia Pacific League of Associations for Rheumatology and Wiley Publishing Asia Pty Ltd.
Similar articles
-
Comparison of patients with ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA) from a single rheumatology clinic in New Delhi.Int J Rheum Dis. 2015 Sep;18(7):736-41. doi: 10.1111/1756-185X.12579. Epub 2015 Jul 14. Int J Rheum Dis. 2015. PMID: 26172961
-
Do patients with non-radiographic axial spondylarthritis differ from patients with ankylosing spondylitis?Arthritis Care Res (Hoboken). 2012 Sep;64(9):1415-22. doi: 10.1002/acr.21688. Arthritis Care Res (Hoboken). 2012. PMID: 22505331
-
[Establishment of the current classification criteria for axial spondylarthritis, rheumatoid arthritis and SLE in routine practice of German rheumatologists].Z Rheumatol. 2019 Dec;78(10):979-986. doi: 10.1007/s00393-019-0677-9. Z Rheumatol. 2019. PMID: 31346705 German.
-
Non-radiographic axial spondyloarthritis: what is it?Clin Exp Rheumatol. 2014 Jan-Feb;32(1):1-4. Epub 2013 Sep 10. Clin Exp Rheumatol. 2014. PMID: 24021580 Review.
-
Clinical practice recommendations for the use of imaging in the diagnosis and management of axial spondyloarthritis in Taiwan.Int J Rheum Dis. 2020 Jan;23(1):24-36. doi: 10.1111/1756-185X.13679. Epub 2019 Dec 13. Int J Rheum Dis. 2020. PMID: 31833212
Cited by
-
Is Treatment in Patients With Suspected Nonradiographic Axial Spondyloarthritis Effective? Six-Month Results of a Placebo-Controlled Trial.Arthritis Rheumatol. 2021 May;73(5):806-815. doi: 10.1002/art.41607. Epub 2021 Mar 24. Arthritis Rheumatol. 2021. PMID: 33277982 Free PMC article. Clinical Trial.
-
Ixekizumab Improves Patient-Reported Outcomes in Non-Radiographic Axial Spondyloarthritis: Results from the Coast-X Trial.Rheumatol Ther. 2021 Mar;8(1):135-150. doi: 10.1007/s40744-020-00254-z. Epub 2020 Dec 7. Rheumatol Ther. 2021. PMID: 33284423 Free PMC article.
-
Non-Radiographic Axial Spondyloarthritis (nr-axSpA): Advances in Classification, Imaging and Therapy.Rheumatol Ther. 2019 Jun;6(2):165-177. doi: 10.1007/s40744-019-0146-6. Epub 2019 Feb 20. Rheumatol Ther. 2019. PMID: 30788779 Free PMC article. Review.
-
Australian Consensus Statements for the Assessment and Management of Non-radiographic Axial Spondyloarthritis.Rheumatol Ther. 2022 Feb;9(1):1-24. doi: 10.1007/s40744-021-00416-7. Epub 2021 Dec 28. Rheumatol Ther. 2022. PMID: 34962620 Free PMC article.
-
A Fifty-Two-Week, Randomized, Placebo-Controlled Trial of Certolizumab Pegol in Nonradiographic Axial Spondyloarthritis.Arthritis Rheumatol. 2019 Jul;71(7):1101-1111. doi: 10.1002/art.40866. Epub 2019 May 28. Arthritis Rheumatol. 2019. PMID: 30848558 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
